This article is more than 5 years old. Information may no longer be current.

Notal Vision names new CEO

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Notal Vision CEO Quinton Oswald will step down from the post at the end of 2018, and Susan Orr, OD, the company’s current chief medical officer and vice president of medical affairs, has been appointed to the position, according to a press release.

Orr will take over as of Jan. 1, 2019.

Oswald will continue to serve on the company’s board of directors, and Grace Chang, MD, PhD, will become chief medical officer.

“Notal Vision is revolutionizing the field of home diagnostics for retinal disease, and I look forward to continuing our progress and further innovating as chief executive officer,” Orr said in the release. “I am honored to be following in the footsteps of Quinton Oswald, who has always sought out disruptive and innovative therapies and technology in the retina space.”